DB17599ExperimentalProtein Based Therapies
NP-6A4 is a peptide designed to specifically bind and activate angiotensin II receptor type 2 (AT2R). It has an Orphan Drug designation from the FDA for pediatric cardiomyopathy.
- Mechanism
- Curator reviewed
Pharmacologically active on Type-2 angiotensin II receptor
- Code names
- NP-6A4
Resolves to
Targets
What you can answer from here — as of July 08, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with NP-6A4, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account